A team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells...
Read more
Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common. An international team has now test in animal models a new "promising therape...
Read more
Aura Biosciences today announced positive data from a completed Phase 1 window of opportunity trial of bel-sar (AU-011) in patients with NMIBC. These data were presented by Dr. Seth Lerner as a late b...
Read more
The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.
Read more
On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Cancer’. Funded by the Spanish Association Against C...
Read more
Las células de melanoma, el cáncer de piel más agresivo, producen una proteína que bloquea el reconocimiento y eliminación del tumor por parte del sistema inmunitario, las defensas naturales del ...
Read more
The research identified differences in the proteins of EVs from oviductal fluid, crucial for embryonic development and maternal-embryo interaction.
Read more
Regenerative medicine has advanced significantly in recent decades, and one of the most promising discoveries in this field is exosomes. These tiny extracellular vesicles are revolutionizing how we un...
Read more
Researchers from the Sant Pau Research Institute (IR Sant Pau) have demonstrated, in a preclinical study, the effectiveness of a targeted nanotoxin in inhibiting colorectal cancer growth. The study, p...
Read more
Identifican características clínicas y moleculares específicas del cáncer de mama asociado al embarazo (PABC) que abren la posibilidad de orientar futuras estrategias terapéuticas personalizadas ...
Read more
La colaboración del Complejo Asistencial Universitario de Salamanca a través del IBSAL y del Hospital Virgen de Rocío, mediante el Instituto de Biomedicina de Sevilla, ha logrado la financiación d...
Read more
Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regulatory authority (AEMPS).
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
